uniQure Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into uniQure (QURE)
uniQure's four-year AMT-130 Huntington's disease benefit came in smaller than its three-year result, and QURE shares plummeted. SueWallSt notifies investors of a pending investigation into potential securities law violations. NEW YORK, Sept. 29, 2026 /PRNewswire/ -- Shares of uniQure N.V....
Covered in this story
Call it yourself
No calls on $AMT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on American Tower →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.